Tag: bempedoic
Esperion Announces Two NEXLETOL® (bempedoic acid) Data Presentations at the Amer…...
ANN ARBOR, Mich., April 03, 2022 (GLOBE NEWSWIRE) -- Esperion ESPR today presented two new analyses from its clinical development program...
Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic...
- Patients with atherosclerotic cardiovascular disease (ASCVD) on maximally tolerated statins and treated with NEXLETOL predicted to experience a 3.3% further absolute reduction...
NEXLETOL® (bempedoic acid) Tablet, ezetimibe and atorvastatin combination lowered bad cholesterol...
- Results of bempedoic acid, ezetimibe and atorvastatin triple therapy study published in March issue of Atherosclerosis - - Combining three orally...